October 18, 2019
A Delaware federal judge on Friday transferred AstraZeneca AB's suit accusing Mylan Pharmaceuticals Inc. of infringing patents for its asthma treatment Symbicort to West Virginia court, invoking the U.S. Supreme Court's 2017 TC Heartland decision.